+ All Categories
Home > Documents > Managed Care 11

Managed Care 11

Date post: 07-Apr-2018
Category:
Upload: faiza-sibtain
View: 221 times
Download: 0 times
Share this document with a friend

of 19

Transcript
  • 8/6/2019 Managed Care 11

    1/19

    MANAGED PATIENT CARE

  • 8/6/2019 Managed Care 11

    2/19

    MANAGED CARE

    y An organized health care delivery system

    designed to improve both the quality and

    the accessibility of health care, including

    pharmaceutical care, while containing costs.

  • 8/6/2019 Managed Care 11

    3/19

  • 8/6/2019 Managed Care 11

    4/19

    WHAT IS A MANAGED CARE PHARMACIST?

    y The areas of opportunities for pharmacists to coordinate patientcare include but are not limited to data integration,communication management with physicians and patients,

    outcomes research efforts, drug utilization review, diseasemanagement, academic detailing, cost analysis programs, andpharmacy benefit design.

    y In addition, pharmacists are able to qualify and quantifythe results of different therapies and programs, and

    therefore add value to the health care team.

  • 8/6/2019 Managed Care 11

    5/19

    NEED OF MANAGED CARE IN HEALTH

    CARE SYSTEM

    y To provide comprehensive pharmaceutical care and to work

    directly with other health care providers to determine the

    most effective pharmaceutical treatment for patients.

  • 8/6/2019 Managed Care 11

    6/19

    ASSUMPTIONSWITHMANAGED CARE

    y If you keep people healthy, you reduce costs.

    y If you only give people what they need (as opposed to what

    they want), you can reduce costs.

    yIf you make providers and patients aware of costs, they will

    be more prudent in their use of services.

  • 8/6/2019 Managed Care 11

    7/19

    HOW DO MANAGED CARE PLANS AFFECT QUALITY

    OF CARE?

    y Studies have shown that elderly, poor and chronically ill

    patients have worse physical outcomes under Managed

    care.

    y Hospitals under managed care plans more frequentlydeny admission or prematurely discharge mentally ill

    patients.

  • 8/6/2019 Managed Care 11

    8/19

    POTENTIAL BENEFITS PATIENTS

    y Less over-treatment

    y More preventive care

    y Lower cost

    y Minimal paperwork

    y Low or no co-payment and deductibles

  • 8/6/2019 Managed Care 11

    9/19

    POTENTIAL BENEFITS PHYSICIANS

    y Lower practice start-up costs

    y Dependable income

    y Regular hours

    y Structured practice

    y Incentives for cost-effective care

    y Assured patients

  • 8/6/2019 Managed Care 11

    10/19

    POTENTIAL BURDENS PATIENTS

    y Incomprehensible benefit plans

    y Limits on specialty services, hospitalization, etc.

    y Physician is no longer the patients advocate

  • 8/6/2019 Managed Care 11

    11/19

    POTENTIAL BURDENS PAYERS

    y Complex health care plans

    y Inadequate data concerning outcomes, quality of care

    y Concerns about price-fixing, monopolization

    y Uncertainty concerning liability

  • 8/6/2019 Managed Care 11

    12/19

    Choice

    Cost Quality

    Conflicts

  • 8/6/2019 Managed Care 11

    13/19

  • 8/6/2019 Managed Care 11

    14/19

    .

    y .

    TYPES OF HEALTH ECONOMICS EVALUATION

    Types of healtheconomic evluation

    CBACost benefit

    analysis

    CEACost effective

    analysis

    CUACost utility analysis

  • 8/6/2019 Managed Care 11

    15/19

    DUR

    y Process used to assess the appropriateness of drug therapy

    by engaging in the evaluation of data on drug use in a given

    health care environment against predetermined criteria and

    standards

  • 8/6/2019 Managed Care 11

    16/19

    DUR INCLUDES.

    y ABC / VENANALYSIS

    y High cost, high volume, clinically important drugs are identified by ABC / VENanalysis.

    y ABCANALYSIS

    y ABC analysis is the method by which drugs are divided according to their

    annual usage (unit cost times annual consumption)y ClassA items 1020% of the items that account for 7580% of the funds

    spent

    y Class B items 1020% of items and 1520% of expenditures

    y Class C items 6080% of items and 510% of expenditures

    y ABC analysis can be used to give priority to class A items in making drug

    selection and procurement decisions as well as for inclusion in DUR.

  • 8/6/2019 Managed Care 11

    17/19

    VEN ANALYSIS

    y VENANALYSIS

    y Setting priorities for drug selection, purchasing and reviewing in which drugsare classified according to their health impact

    y V = vital drugs

    y E = essential drugs

    y N = non-essential drugsy Vital drugs = that are potentially life-saving (e.g. vaccines) that have

    significant withdrawal side-effects such that a regular supply is necessary (e.g.propranolol, insulin, steroids)

    y Essential drugs = that are effective against less severe, but significant formsof illness

    y Non-essential= for minor or self-limiting illnesses, drugs that are ofquestionable efficacy, and drugs that have a high cost for marginal therapeuticadvantage.

  • 8/6/2019 Managed Care 11

    18/19

    PHYSICIANS REACT TO MANAGED CARE

    y The general reaction of physicians to managed care is negative:

    y Quality care is being denied.

    y Managed care is profit-driven.

    y Managed care will bring on a single payer national plan.

    y Physicians get hassled and burdened with paperwork.

    y Traditional physician-patient relationship is poisoned.

    y Physicians income is reduced.

    y Managed care induces physicians to be manipulators.

  • 8/6/2019 Managed Care 11

    19/19

    CONCLUSION


Recommended